NDMA in Zantac
On April 1, 2020, the US Food and Drug Administration (FDA) requested that the manufacturers of Zantac and other versions of ranitidine immediately remove the medications from the market. The recall followed extensive testing by the FDA and other independent laboratories that discovered there could be high levels of N-nitrosodimethylamine (NDMA), a cancer-causing carcinogen, in the medications. At Cannon Law, we want to discuss what NDMA is and how it can affect those who take these medications.
What is NDMA?
In 2019, independent tests conducted by Valisure, an online pharmacy, revealed that there were extremely high levels of N-nitrosodimethylamine (NDMA) in many versions of prescription and over the counter Zantac and other ranitidine products. These tests were followed by testing from the FDA, which found similarly high levels of the dangerous substance.
NDMA has been labeled by the Environmental Protection Agency (EPA) and the World Health Organization (WHO) as a cancer-calling carcinogen in humans. According to Dr. William Mitch, a professor of civil and environmental engineering at Stanford University, NDMA is a carcinogen because it modifies a person’s DNA.
According to the FDA, it is safe for humans to consume only 96 nanograms of NDMA each day. However, testing has shown that a Zantac 150 mg tablet could contain as much as 2,500,000 nanograms of NDMA, far exceeding the allowable levels safe for humans. NDMA has been suggested to be linked to occurrences of various types of cancer, including the following:
- Bladder cancer
- Colorectal cancer
- Liver cancer
- Lung cancer
- Nasal cancer
- Pancreatic cancer
- Esophageal cancer
- Gastric (stomach) cancer
- Kidney cancer
Ranitidine has been linked to several other severe side effects, such as stomach pain, easy bleeding or bruising, chest pain, shortness of breath, and more.
Why Turn to Cannon Law for Your Case?
The heightened levels of NDMA are concerning, and there have been more than 100 lawsuits filed against the makers of Zantac and other ranitidine products in federal court. The plaintiffs in these cases have said that they believe Zantac and other ranitidine medications caused them to develop cancer.
If you or a loved one have taken any of these medications and subsequently been diagnosed with cancer, you are going to need a team with extensive experience handling these cases by your side. At Cannon Law, we have the resources necessary to conduct a thorough investigation into your case. We will work with trusted healthcare experts to thoroughly review your medical records and properly determine whether your cancer could have been caused by taking these medications.
What Kind of Compensation Is Available for a Zantac Case?
If you or somebody you love has taken Zantac or other ranitidine medications and subsequently been diagnosed with cancer, there may be various types of compensation available in your case. At Cannon Law, our qualified and experienced Colorado product liability attorneys will investigate your claim and work to secure the following conversation:
- Coverage of any medical expenses related to this product
- Lost income and benefits if you have been unable to work
- Pain and suffering damages
- Loss of personal enjoyment damages
- Possible punitive damages against the manufacturers of these medications